Cambrian Biopharma
Organisation
Named in competing interests
When to Trust Epigenetic Clocks: Avoiding False Positives in Aging Interventions
Consulting or advice, Fees or honoraria, 1 Oct 2026
Responsiveness of epigenetic aging biomarkers to longevity interventions in humans
Consulting or advice, Fees or honoraria, 21 Aug 2026
DNA Methylation Signatures of Cellular Senescence Are Not Reversed by Senolytic Treatment
Consulting or advice, Fees or honoraria, 1 Mar 2026
TranslAGE: A Comprehensive Platform for Systematic Validation of Epigenetic Aging Biomarkers
Consulting or advice, Fees or honoraria, 19 Oct 2025
Consulting or advice, Fees or honoraria, 15 Sept 2025
Sources: pubmed.ncbi.nlm.nih.gov
Papers
Phase 1b Study of AMPK/Mitochondrial Activator ATX-304 in Prediabetic Obese Participants
ADA Scientific Sessions 2026 abstract, 5 Jun 2026